Johan Lundberg

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Adjungerad professor i psykiatri vid institutionen för klinisk
neurovetenskap från 1 februari 2022.
Primär anställning: Vårdprocessansvarig överläkare och chef för
Sektionen för affektiva sjukdomar, Norra Stockholms psykiatri
Forskargruppsledare, se länken nedan.

Artiklar

Journal article: LAKARTIDNINGEN. 2024;121:23195

[Psychedelic psychiatry].

López E; Yngwe H; Beckman M; Tiger M; Hieronymus F; Lundberg J
Journal article: TRANSLATIONAL PSYCHIATRY. 2024;14(1):175

Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic.

Tiger M; Castelpietra G; Wesselhoeft R; Lundberg J; Reutfors J
Article: JAMA PSYCHIATRY. 2024;81(4):426

Antidepressant Use and Manic Episodes in Children and Adolescents With Unipolar Depression.

Boström AED; Andersson P; Lundberg J
Article: JOURNAL OF ECT. 2024

Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode: A Register-Based Study.

Popiolek K; Arnison T; Boden R; Ekman CJ; Lundberg J; Strandberg P; Nordenskjöld A
Article: SCHIZOPHRENIA. 2024;10(1):5

Challenges and opportunities in the diagnosis and treatment of early-onset psychosis: a case series from the youth affective disorders clinic in Stockholm, Sweden.

Lundberg M; Andersson P; Lundberg J; Desai Boström AE
Journal article: NEUROSCIENCE APPLIED. 2024;3:103929

Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms

McCulloch DE-W; Lopez JP; Dalla C; Castrén E; Erritzoe D; Frokjaer VG; Lundberg J; Preller KH; Fisher PM; Knudsen GM
Journal article: NEUROSCIENCE APPLIED. 2024;3:103938

Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects

McCulloch DE-W; Liechti ME; Kuypers KP; Nutt D; Lundberg J; Stenbæk DS; Goodwin GM; Gründer G; Butlen-Ducuing F; Haberkamp M; Thirstrup S; Knudsen GM
Article: JAMA PSYCHIATRY. 2023;80(12):1218-1225

Determinants and Outcomes of Suicidal Behavior Among Patients With Major Depressive Disorder.

Lundberg J; Cars T; Lampa E; Ekholm Selling K; Leval A; Gannedahl A; Själin M; Björkholm C; Hellner C
Article: JOURNAL OF ECT. 2023;39(4):227-234

Anorexia Nervosa With Comorbid Severe Depression: A Systematic Scoping Review of Brain Stimulation Treatments.

Andersson P; Jamshidi E; Ekman C-J; Tedroff K; Björkander J; Sjögren M; Lundberg J; Jokinen J; Desai Boström AE
Article: INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH. 2023;32(4):e1960

Mapping length of inpatient treatment duration and year-wise relapse rates in eating disordered populations in a well-defined Western-European healthcare region across 1998-2020.

Andersson P; Jamshidi E; Ekman C-J; Tedroff K; Björkander J; Sjögren M; Lundberg J; Jokinen J; Desai Boström AE
Article: JOURNAL OF ECT. 2023

Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode: A Register-Based Study.

Strandberg P; Nordenskjöld A; Bodén R; Ekman CJ; Lundberg J; Popiolek K
Article: JAMA PSYCHIATRY. 2023;80(8):796-802

Association of Bipolar Disorder Diagnosis With Suicide Mortality Rates in Adolescents in Sweden.

Andersson P; Jokinen J; Jarbin H; Lundberg J; Desai Boström AE
Article: BRAIN, BEHAVIOR, AND IMMUNITY - HEALTH. 2023;31:100665

Inverse association of anti-inflammatory prescription fills and suicide-related mortality in young adults: Evidence from a nationwide study of Swedish regions, 2006-2021.

Andersson P; Lundberg J; Jarbin H; Jokinen J; Desai Boström AE
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;329:50-54

Outcome of transcranial magnetic intermittent theta-burst stimulation in the treatment of depression - A Swedish register-based study.

Ekman CJ; Popiolek K; Bodén R; Nordenskjöld A; Lundberg J
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2023;26(4):241-248

Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [11C]AZ10419369 Positron Emission Tomography Study.

Tangen Ä; Veldman ER; Svensson J; Tiger M; Nord M; Sorjonen K; Andersson M; Plavén-Sigray P; Varrone A; Halldin C; Varnäs K; Borg J; Lundberg J
Article: NATURE COMMUNICATIONS. 2023;14(1):1281

Regional clozapine, ECT and lithium usage inversely associated with excess suicide rates in male adolescents.

Desai Boström AE; Andersson P; Rask-Andersen M; Jarbin H; Lundberg J; Jokinen J
Article: JAMA PSYCHIATRY. 2023;80(2):167-175

Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.

Lundberg J; Cars T; Lööv S-Å; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
Journal article: NEUROSCIENCE APPLIED. 2023;2:101035

Glutamate 5 receptor availability differences in twins discordant for autism and controls, do shared genetics matter

Griffioen G; Andersson M; Tangen Ä; Bolin M; Farde L; Halldin C; Bölte S; Lundberg J; Borg J
Journal article: BRAIN STIMULATION. 2023;16(1):385-386

Outcome of transcranial magnetic intermittent theta-burst stimulation in the treatment of depression - a Swedish register-based study

Ekman CJ; Popiolek K; Bodén R; Nordenskjöld A; Lundberg J
Article: MOLECULAR PSYCHIATRY. 2022;27(12):5096-5112

International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators.

Price RB; Kissel N; Baumeister A; Rohac R; Woody ML; Ballard ED; Zarate CA; Deakin W; Abdallah CG; Feder A; Charney DS; Grunebaum MF; Mann JJ; Mathew SJ; Gallagher B; McLoughlin DM; Murrough JW; Muthukumaraswamy S; McMillan R; Sumner R; Papakostas G; Fava M; Hock R; Phillips JL; Blier P; Shiroma P; Šóš P; Su T-P; Chen M-H; Tiger M; Lundberg J; Wilkinson ST; Wallace ML
Article: NEUROPSYCHOPHARMACOLOGY. 2022;47(10):1863-1868

In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study.

Svensson JE; Tiger M; Plavén-Sigray P; Halldin C; Schain M; Lundberg J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2022;146(1):51-63

Clinical and societal burden of incident major depressive disorder: A population-wide cohort study in Stockholm.

Lundberg J; Cars T; Lööv S-Å; Söderling J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2022;146(1):74-84

Suicidal ideation and ECT, ECT and suicidal ideation: A register study.

Sienaert P; Brus O; Lambrichts S; Lundberg J; Nordanskog P; Obbels J; Verspecht S; Vansteelandt K; Nordenskjöld A
Article: TRANSLATIONAL PSYCHIATRY. 2022;12(1):226

Patterns of activity correlate with symptom severity in major depressive disorder patients.

Spulber S; Elberling F; Svensson J; Tiger M; Ceccatelli S; Lundberg J
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2022;42(4):630-641

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography.

Veldman ER; Varrone A; Varnäs K; Svedberg MM; Cselényi Z; Tiger M; Gulyás B; Halldin C; Lundberg J
Article: NORDIC JOURNAL OF PSYCHIATRY. 2022;76(2):96-103

Validity of diagnoses, treatment dates, and rating scales in the Swedish national quality register for electroconvulsive therapy.

Ahmad I; Sandberg M; Brus O; Ekman CJ; Hammar Å; Landén M; Lundberg J; Nordanskog P; von Knorring L; Nordenskjöld A
Article: NPJ MENT HEALTH RES. 2022;1(1):13

Youth with severe mental illness and complex non-somatic motor abnormalities: conflicting conceptualizations and unequal treatment.

Andersson P; Wachtel LE; Lundberg J; Jamshidi E; Bring J; Rask-Andersen M; Jarbin H; Jokinen J; Desai Boström AE
Journal article: NEUROSCIENCE APPLIED. 2022;1:100179

Treatment resistant depression: epidemiology and consequences – a population wide study

Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
Journal article: NEUROSCIENCE APPLIED. 2022;1:100492

The cognitive effects of ketamine for SSRI-resistant depression in relation to serotonin 1B receptor binding

Tiger M; Veldman E; Lundeberg M; Tangen Ä; Ekman CJ; Lundberg J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;290:240-244

P11 (S100A10) as a potential predictor of ketamine response in patients with SSRI-resistant depression.

Veldman ER; Mamula D; Jiang H; Tiger M; Ekman C-J; Lundberg J; Svenningsson P
Article: TRANSLATIONAL PSYCHIATRY. 2021;11(1):264

Serotonin transporter availability increases in patients recovering from a depressive episode.

Svensson JE; Svanborg C; Plavén-Sigray P; Kaldo V; Halldin C; Schain M; Lundberg J
Article: MOLECULAR PSYCHIATRY. 2021;26(5):1647-1658

Serotonin transporter availability in adults with autism-a positron emission tomography study.

Andersson M; Tangen Ä; Farde L; Bölte S; Halldin C; Borg J; Lundberg J
Article: MEDICINE. 2021;100(14):e25273

Repetitive transcranial magnetic stimulation in major depression: A three-arm parallel-group dose-response randomized pilot trial.

Johansson K; Adler M; Båve U; Ekman C-J; Lundberg J
Article: NORDIC JOURNAL OF PSYCHIATRY. 2021;75(3):201-206

Relapse risk after in-ward electroconvulsive therapy for acute polymorphic psychotic disorder.

Kalling S; Brus O; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: NEUROIMAGE. 2021;226:117523

Low convergent validity of [11C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [11C]FLB 457.

Freiburghaus T; Svensson JE; Matheson GJ; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Article: FRONTIERS IN NEUROSCIENCE. 2021;15:698633

Plasma Levels of Brain-Derived Neurotrophic Factor and S100B in Relation to Antidepressant Response to Ketamine.

Jiang H; Veldman ER; Tiger M; Ekman C-J; Lundberg J; Svenningsson P
Article: JOURNAL OF ECT. 2020;36(4):272-278

The Effect of Pulse Width on Subjective Memory Impairment and Remission Rate 6 Months After Electroconvulsive Therapy.

Tornhamre E; Ekman CJ; Hammar Å; Landen M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: JOURNAL OF ECT. 2020;36(4):242-246

Electroconvulsive Therapy in Depression: Improvement in Quality of Life Depending on Age and Sex.

Güney P; Ekman CJ; Hammar Å; Heintz E; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: JOURNAL OF ECT. 2020;36(3):168-171

The Incidence of Dental Fracturing in Electroconvulsive Therapy in Sweden.

Göterfelt L; Ekman CJ; Hammar Å; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: NORDIC JOURNAL OF PSYCHIATRY. 2020;74(5):359-365

Physician estimated vs. self-reported subjective memory in depressed patients treated with electroconvulsive therapy.

Stengård J; Ekman CJ; Båve U; Lundahl A; Abawi M; Adler M; Landén M; Lundberg J
Article: TRANSLATIONAL PSYCHIATRY. 2020;10(1):159

A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression.

Tiger M; Veldman ER; Ekman C-J; Halldin C; Svenningsson P; Lundberg J
Article: PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2020;74(4):263-269

[11 C]raclopride positron emission tomography study of dopamine-D2/3 receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjects.

Tiger M; Svensson J; Liberg B; Saijo T; Schain M; Halldin C; Farde L; Lundberg J
Journal article: SCHIZOPHRENIA BULLETIN OPEN. 2020;1(1):sgaa019

Predictors of Treatment Response to Electroconvulsive Therapy in Schizophrenia—A Nationwide Registry-Based Study

Stenmark L; Popiolek K; Bodén R; Brus O; Hammar Å; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: JOURNAL OF ECT. 2019;35(4):264-271

Rehospitalization of Postpartum Depression and Psychosis After Electroconvulsive Therapy: A Population-Based Study With a Matched Control Group.

Rönnqvist I; Brus O; Hammar Å; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: NEUROIMAGE. 2019;202:116143

Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain.

Svensson JE; Schain M; Plavén-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2019;140(3):196-204

Electroconvulsive therapy in bipolar depression - effectiveness and prognostic factors.

Popiolek K; Bejerot S; Brus O; Hammar Å; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: BJPSYCH OPEN. 2019;5(3):e46

Lithium for suicide and readmission prevention after electroconvulsive therapy for unipolar depression: population-based register study.

Brus O; Cao Y; Hammar Å; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2019;22(4):278-285

Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2.

Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Hirano Y; Halldin C; Lundberg J
Article: SCIENCE TRANSLATIONAL MEDICINE. 2018;10(461):eaam8434

GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models.

Horder J; Andersson M; Mendez MA; Singh N; Tangen Ä; Lundberg J; Gee A; Halldin C; Veronese M; Bölte S; Farde L; Sementa T; Cash D; Higgins K; Spain D; Turkheimer F; Mick I; Selvaraj S; Nutt DJ; Lingford-Hughes A; Howes OD; Murphy DG; Borg J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;235:258-264

Improvement of postpartum depression and psychosis after electroconvulsive therapy: A population-based study with a matched comparison group.

Rundgren S; Brus O; Båve U; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;226:146-154

Rehospitalization and suicide following electroconvulsive therapy for bipolar depression-A population-based register study.

Popiolek K; Brus O; Elvin T; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: PSYCHIATRY RESEARCH-NEUROIMAGING. 2017;267:15-21

Associations between cognition and serotonin receptor 1B binding in patients with major depressive disorder - A pilot study.

Tangen Ä; Borg J; Tiger M; Varnäs K; Sorjonen K; Lindefors N; Halldin C; Lundberg J
Article: EUROPEAN PSYCHIATRY. 2017;45:154-160

Self-assessed remission rates after electroconvulsive therapy of depressive disorders.

Brus O; Cao Y; Gustafsson E; Hultén M; Landen M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: NORDIC JOURNAL OF PSYCHIATRY. 2017;71(6):405-410

Improvement of cycloid psychosis following electroconvulsive therapy.

Holm J; Brus O; Båve U; Landen M; Lundberg J; Nordanskog P; von Knorring L; Nordenskjöld A
Article: JOURNAL OF ECT. 2017;33(2):96-103

Subjective Memory Immediately Following Electroconvulsive Therapy.

Brus O; Nordanskog P; Båve U; Cao Y; Hammar Å; Landén M; Lundberg J; Nordenskjöld A
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(5):504-514

Distribution and levels of 5-HT1B receptors in anterior cingulate cortex of patients with bipolar disorder, major depressive disorder and schizophrenia - An autoradiography study.

Veldman ER; Svedberg MM; Svenningsson P; Lundberg J
Article: PSYCHIATRY RESEARCH-NEUROIMAGING. 2016;253:36-42

Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder.

Tiger M; Farde L; Rück C; Varrone A; Forsberg A; Lindefors N; Halldin C; Lundberg J
Article: JOURNAL OF ECT. 2015;31(4):263-267

Electroconvulsive Therapy in Sweden 2013: Data From the National Quality Register for ECT.

Nordanskog P; Hultén M; Landén M; Lundberg J; von Knorring L; Nordenskjöld A
Article: NEUROIMAGE. 2015;112:225-231

Diurnal and seasonal variation of the brain serotonin system in healthy male subjects.

Matheson GJ; Schain M; Almeida R; Lundberg J; Cselényi Z; Borg J; Varrone A; Farde L; Cervenka S
Article: NEUROIMAGE. 2014;103:303-308

Distinct regional age effects on [11C]AZ10419369 binding to 5-HT1B receptors in the human brain.

Nord M; Cselenyi Z; Forsberg A; Rosenqvist G; Tiger M; Lundberg J; Varrone A; Farde L
Article: SYNAPSE. 2014;68(10):480-483

No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [(11) C]AZ10419369 binding measured with PET in healthy volunteers.

Tiger M; Svenningsson P; Nord M; Jabre S; Halldin C; Lundberg J
Article: PSYCHIATRY RESEARCH. 2014;223(2):164-170

Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder.

Tiger M; Rück C; Forsberg A; Varrone A; Lindefors N; Halldin C; Farde L; Lundberg J
Article: FRONTIERS IN PSYCHIATRY. 2014;5:176

Functional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances.

Liberg B; Klauser P; Harding IH; Adler M; Rahm C; Lundberg J; Masterman T; Wachtler C; Jonsson T; Kristoffersen-Wiberg M; Pantelis C; Wahlund B
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2013;23(10):1190-1198

5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.

Stenkrona P; Halldin C; Lundberg J
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2012;15(8):1167-1172

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.

Lundberg J; Tiger M; Landén M; Halldin C; Farde L
Article: BIOLOGICAL PSYCHIATRY. 2009;66(5):477-485

Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men.

Henningsson S; Borg J; Lundberg J; Bah J; Lindström M; Ryding E; Jovanovic H; Saijo T; Inoue M; Rosén I; Träskman-Bendz L; Farde L; Eriksson E
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2009;12(6):783-792

Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans.

Borg J; Henningsson S; Saijo T; Inoue M; Bah J; Westberg L; Lundberg J; Jovanovic H; Andrée B; Nordstrom A-L; Halldin C; Eriksson E; Farde L
Article: NEUROIMAGE. 2008;39(3):1408-1419

Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.

Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordström A-L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2007;10(6):777-785

PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.

Lundberg J; Christophersen JS; Petersen KB; Loft H; Halldin C; Farde L
Article: PSYCHOPHARMACOLOGY. 2007;195(3):425-433

A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.

Lundberg J; Borg J; Halldin C; Farde L
Article: LAKARTIDNINGEN. 2007;104(26-27):2002-2003

[Coming generation of researchers--a question of fate for psychiatry].

Cervenka S; Reutfors J; Lundberg J; Papadopoulos F; Lundén E; Sjöström C; Björklund L
Article: PSYCHIATRY RESEARCH. 2006;148(2-3):185-193

A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria.

Jovanovic H; Cerin A; Karlsson P; Lundberg J; Halldin C; Nordström A-L
Article: SYNAPSE. 2006;60(3):256-263

Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study.

Lundberg J; Halldin C; Farde L
Article: PSYCHOPHARMACOLOGY. 2006;185(3):389-394

Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions--a strategy in translational psychopharmacology.

Borg J; Andrée B; Lundberg J; Halldin C; Farde L
Article: SYNAPSE. 2005;58(3):173-183

[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.

Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
Article: JOURNAL OF NUCLEAR MEDICINE. 2005;46(9):1505-1515

Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.

Lundberg J; Odano I; Olsson H; Halldin C; Farde L
Article: NEUROCHEMISTRY INTERNATIONAL. 2004;45(5):773-781

Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data.

Cselényi Z; Lundberg J; Halldin C; Farde L; Gulyás B
Visa fler

Alla övriga publikationer

Letter: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023;82(19):e177

Beyond the Surface: Scrutinizing Methodological Biases in a Study on iCBT for Atrial Fibrillation.

Desai Boström AE; Lundberg J
Preprint: MEDRXIV. 2023

Correlations between patterns of activity and the response to treatment yield distinct signatures for different antidepressive treatments

Spulber S; Elberling F; Ceccatelli S; Gärde M; Tiger M; Lundberg J
Editorial comment: LANCET. 2023;401(10378):714-716

The therapeutic potential of psychedelics: the European regulatory perspective.

Butlen-Ducuing F; McCulloch DE-W; Haberkamp M; Mattila T; Bałkowiec-Iskra E; Aislaitner G; Balabanov P; Lundberg J; Stenbæk DS; Elferink A; Knudsen GM; Thirstrup S
Conference publication: PROCEEDINGS OF THE INTERNATIONAL SOCIETY FOR MAGNETIC RESONANCE IN MEDICINE ... SCIENTIFIC MEETING AND EXHIBITION.. 2022

Ketamine Induced Glutamate Alternations in Treatment-Resistant Depression. A 1H-MRS randomised placebo controlled study.

Sitnikov R; Tiger M; Lundberg J
Book chapter: TRANSLATIONAL RESEARCH METHODS FOR MAJOR DEPRESSIVE DISORDER: NEUROMETHODS. 2022;p. 227-240

Molecular Imaging of Major Depressive Disorder with Positron Emission Tomography: Translational Implications for Neurobiology and Treatment

Tiger M; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;53:S636-S637

Epidemiology of major depression and intentional self-harm from a total-population cohort in the greater Stockholm region

Bjorkholm C; Gannedahl A; Leval A; Cars T; Sjalin M; Hellner C; Lundberg J
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):169-170

Centrum semiovale as reference region - An evaluation of methods to quantify [18F]FPEB PET binding data in man

Andersson M; Varnas K; Halldin C; Borg J; Farde L; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;40:S149-S150

Outcome of treatment in clinical practice compared to a clinical trial in treatment-resistant depression: a matched adjusted indirect comparison

Bjorkholm C; Gannedahl A; Leval A; Rive B; Cars T; Sjalin M; Van Sanden S; Hellner C; Lundberg J
Preprint: BIORXIV. 2020

Low convergent validity of [11C]raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [11C]FLB 457

Freiburghaus T; Svensson JE; Matheson GJ; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Letter: NEUROIMAGE. 2020;207:116371

In response to the letter "[11C]raclopride and extrastriatal binding to D2/3 receptors".

Svensson JE; Schain M; Plavén-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S172

Treatment resistant depression in Stockholm: Disease burden estimations, treatment trajectories and healthcare consumption from a longitudinal population-based cohort

Lundberg J; Hellner C; Leval A; Sjalin M; Ek M; Gannedahl A; Tiihonen J; Loov SA; Cars T
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S367

Constructing a real-world evidence arm to quantify the placebo effect in a randomized control trial utilizing electronic-medical record depression scales

Leval A; Rive B; Bjorkholm C; Merclin N; Umuhire D; Gannedahl A; Milz R; Hellner C; Lundberg J; Cars T
Preprint: BIORXIV. 2019

Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain

Svensson JE; Schain M; Plavén-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Review: PSYCHOPHARMACOLOGY. 2018;235(5):1317-1334

The 5-HT1B receptor - a potential target for antidepressant treatment.

Tiger M; Varnäs K; Okubo Y; Lundberg J
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2018;43:S133-S134

Quantification of Norepinephrine Transporter Occupancy of Venlafaxine Extended-Release in Patients With Major Depressive Disorder Using Positron Emission Tomography and Radioligand [18 F]FMeNER-D2

Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asamin Y; Hirano Y; Halldin C; Lundberg J
Conference publication: EUROPEAN PSYCHIATRY. 2018;48:S291

Predictors of response to electroconvulsive therapy in bipolar depression - A population-based register study

Popiolek K; Brus O; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S741-S742

Social cognition in autism spectrum disorder is associated with brain serotonin transporter availability

Tangen A; Andersson M; Nystrom K; Bolte S; Halldin C; Farde L; Lundberg J; Borg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S716-S717

A multicenter positron emission tomography study of GABA receptor availability in adults with autism

Andersson M; Horder J; Mendez M; Tangen A; Lundberg J; Gee A; Halldin C; Veronese M; Bolte S; Sementa T; Cash D; Turkheimer F; Mick S; Selvaraj S; Nutt D; Lingford-Hughes A; Howes O; Murphy D; Borg J
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2017;42:S366-S367

Electroconvulsive Treatment of Patients With Major Depressive Episodes may Normalize Dopamine D2 Receptor Binding Potential in the Executive and Limbic Striatum: A Pilot PET Study

Svensson J; Tiger M; Liberg B; Halldin C; Schain M; Farde L; Lundberg J
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S82-S83

Gender differences in the 5-HT1A receptor and serotonin transporter in the human brain: a PET study

Jovanovic H; Lundberg J; Cerin A; Karlsson P; Halldin C; Nordstrom AL

Forskningsbidrag

Randomized controlled trial of the effect of anesthetic dose during electroconvulsive therapy for major depression

Swedish Research Council

1 January 2024 - 31 December 2025
CAPSI - Cancer related major depression treated with a single dose of pslilocybin - a randomised placebo controlled double blind clinical trial

Swedish Research Council

1 January 2023 - 31 December 2026
The effect of psilocybin on depression symptom severity, peripheral biomarkers and synaptic density – a single dose randomized double blind, placebo-controlled phase 2 PET study

Swedish Research Council

1 January 2022 - 31 December 2024
Neuropeptide Y as a novel treatment for major depression - clinical trial, and translational molecular and imaging studies

Swedish Research Council

1 January 2017 - 31 December 2019
Transdisciplinary Synergies to Disclose Complexity in Neurodevelopmental Disorder Etiologies: A Basic Science and Clinical Twin Study ("RATSS")

Swedish Research Council

1 January 2017 - 31 December 2019
Identification of molecular changes related to treatment of major depressive disorder measured with Positron Emission Tomography.

Swedish Research Council

1 January 2014 - 31 December 2016
Identification of molecular changes related to treatment of major depressive disorder measured with Positron Emission Tomography.

Swedish Research Council

1 January 2014 - 31 December 2019

Anställningar

Adjungerad Professor, Klinisk neurovetenskap, Karolinska Institutet, 2022-2026

Examina och utbildning

Docent, Psykiatri, Karolinska Institutet, 2015
MEDICINE DOKTORSEXAMEN, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2006
Läkarexamen, Karolinska Institutet, 1998

Om mig

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI